Davion Healthcare (DAVI) Stock Price, News & Analysis

Company Overview

Davion Healthcare Plc is a digital healthcare company developing proprietary, non-invasive health monitoring technologies designed to support the early identification of medical anomalies outside traditional clinical environments. The Company's flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. Davion Healthcare Plc is based in DUBLIN.

Key Stats

• Today's Range: $1.65 to $2.24
• 50-Day Range: N/A
• 52-Week Range: $1.65 to $12.30
• Volume: 1.36 million shs
• Average Volume: 3.37 million shs
• Market Capitalization: $42 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/31/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:DAVI
• CIK: 2039072
• Web: www.davionhealthcare.com
• Phone: +35725040052
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 25,000,000
• Free Float: N/A
• Market Cap: $42 million
• Optionable: N/A
• Beta: N/A